Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
Elisabeth L. Metry(Emma Kinderziekenhuis), Hessel Peters‐Sengers(Amsterdam Neuroscience), Michiel J.S. Oosterveld(Emma Kinderziekenhuis), Justine Bacchetta(Université Claude Bernard Lyon 1), Jérôme Harambat(Centre Hospitalier Universitaire de Bordeaux), Viola D’Ambrosio(Università Cattolica del Sacro Cuore), Graham Lipkin(Queen Elizabeth II Medical Centre), Larisa Prikhodina(Pirogov Russian National Research Medical University), Rezan Topaloğlu(Hacettepe University), Laure Collard(Centre Hospitalier Chrétien), Cécile Acquaviva(Hospices Civils de Lyon), Pierre Cochat(Société Nationale des Chemins de Fer Français (France)), Nilufar Mohebbi(University Hospital of Zurich), Lisa J. Deesker(Emma Kinderziekenhuis), Giorgia Mandrile(University of Turin), Casper Franssen(University Medical Center Groningen), Pietro Manuel Ferraro(Università Cattolica del Sacro Cuore), Bodo B. Beck(University of Cologne), Sander F. Garrelfs(Emma Kinderziekenhuis), Cristina Martín-Higueras(Universidad de La Laguna), Shabbir H. Moochhala(Université Claude Bernard Lyon 1), Sally‐Anne Hulton(Birmingham Children's Hospital), Jaap W. Groothoff(University of Amsterdam), Thomas J. Neuhaus(University of Zurich), Eduardo Salido(Universidad de La Laguna)
Cited by 29
Related Papers
Epidemiology of chronic kidney disease in children
|Pediatric Nephrology|2011|963
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834
CKD Prevalence Varies across the European General Population
|Journal of the American Society of Nephrology|2015|588
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4
|Nature Genetics|2006|573
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505